Taysha Gene Therapies, Inc.

NASDAQ:TSHA

Biotechnology

Healthcare
$3.77 +1.53%

+$0.10 today

Market cap
$1.22B
Beta
1.18
P/E (TTM)
-17.7
EPS (TTM)
-$0.35
52W Low $2.25High $7.30

Volume 2.17M

Average 2.73M

Balance Sheet

Inspect the capital base behind the business.

Assets

$343.32M

FY 2025 · Annual

+114.1% YoY

Liabilities

$96.38M

FY 2025 · Annual

+8.5% YoY

Equity

$246.94M

FY 2025 · Annual

+245.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents149.1M87.88M143.94M139.04M319.77M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets6.63M1.19M3.42M892K1.45M
Total Current Assets159.6M96.42M149.87M142.13M324.65M
Property, Plant & Equipment (Net)50.61M25.91M20.41M15.87M16.18M
Goodwill00000
Intangible Assets00000
Long-term Investments2.64M0002.32M
Tax Assets00000
Other Non-current Assets1.11M3.95M2.46M2.37M183K
Total Non-current Assets54.35M29.86M22.86M18.23M18.67M
Total Assets213.96M126.28M172.73M160.36M343.32M
Account Payables21.76M10.95M6.37M3.59M6.28M
Short-term Debt00000
Tax Payables00000
Deferred Revenue033.56M18.11M9.77M0
Other Current Liabilities4.14M4.63M4.99M6.43M10.85M
Total Current Liabilities51.75M62.79M36.76M26.23M26.55M
Long-term Debt37.19M37.97M40.51M43.94M18.17M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities3.74M4.13M1.58M1.31M51.66M
Total Non-current Liabilities66.83M62.54M61.04M62.61M69.83M
Total Liabilities118.57M125.33M97.79M88.84M96.38M
Common Stock01K2K2K3K
Retained Earnings(235.65M)(401.44M)(513.01M)(602.31M)(711.3M)
Accumulated OCI000(4.03M)(192K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity95.38M949K74.94M71.53M246.94M
Total Debt63.09M59.93M61.11M63.18M18.17M
Net Debt(86.01M)(27.95M)(82.83M)(75.86M)(301.6M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$455.4M
Other Current$6.0M
Total Current Assets$461.4M
PP&E (Net)$8.7M
Other Non-current$270.0K
Total Non-current Assets$9.0M
Total Assets$470.4M

Analysis

Selected assets total $470.4M for Latest. The largest visible component is Cash & Equivalents at $455.4M, about 96.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 13, 2026
10-QQuarterly reportAug 11, 2026

How much cash does TSHA have?

Taysha Gene Therapies, Inc. (TSHA) reported $319.77M in cash and equivalents in fiscal 2025.

How much debt does TSHA carry?

Taysha Gene Therapies, Inc. (TSHA) reported $18.17M of total debt, with net debt of -$301.60M.